Natalia L Klyachko Selected Research

Lectins

1/2020

Synthesis and Evaluation of New Trivalent Ligands for Hepatocyte Targeting via the Asialoglycoprotein Receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Natalia L Klyachko Research Topics

Disease

7	Neoplasms (Cancer) 12/2023 - 07/2015
6	Parkinson Disease (Parkinson's Disease) 11/2021 - 04/2010
4	Adenocarcinoma 12/2023 - 07/2015
4	Inflammation (Inflammations) 04/2021 - 01/2011
3	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2023 - 01/2012
2	Bacterial Infections (Bacterial Infection) 12/2023 - 12/2014
2	Uveitis 04/2021 - 01/2015
2	Edema (Dropsy) 04/2021 - 01/2015
2	Hyperemia 04/2021 - 01/2015
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2021
2	Hyperthermia 01/2018 - 12/2015
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2023
1	Experimental Melanoma 12/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Blindness (Hysterical Blindness) 04/2021
1	Eye Diseases (Eye Disease) 04/2021
1	Triple Negative Breast Neoplasms 01/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Rupture 09/2019
1	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 09/2017
1	Cataract (Cataracts) 01/2015
1	Brain Injuries (Brain Injury) 09/2012
1	Neuroinflammatory Diseases 06/2012
1	Disease Progression 04/2010

Drug/Important Bio-Agent (IBA)

7	EnzymesIBA 04/2021 - 01/2011
6	AntioxidantsIBA 04/2021 - 01/2012
6	CatalaseIBA 09/2017 - 01/2011
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 01/2020
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 04/2016
2	CopperIBA 12/2023 - 12/2023
2	ProdrugsIBA 01/2022 - 07/2015
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2018
2	FibrinIBA 04/2021 - 01/2015
2	Superoxide Dismutase-1IBA 04/2021 - 01/2015
2	GlycoconjugatesIBA 01/2021 - 01/2021
2	AcetylgalactosamineIBA 01/2021 - 01/2021
2	Cytostatic AgentsIBA 01/2021 - 01/2021
2	Docetaxel (Taxotere)FDA Link 01/2021 - 07/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2020
1	IonsIBA 12/2023
1	Liposomes (Liposome)IBA 12/2023
1	Amyloid (Amyloid Fibrils)IBA 10/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	Coenzyme A (CoA)IBA 01/2023
1	Oxidoreductases (Dehydrogenase)IBA 01/2023
1	PlatinumIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	CarbonIBA 01/2022
1	betulinIBA 01/2021
1	taxaneIBA 01/2021
1	LectinsIBA 01/2020
1	LigandsIBA 01/2020
1	Asialoglycoprotein ReceptorIBA 01/2020
1	LipidsIBA 09/2019
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018
1	Sepharose (Agarose)IBA 01/2018
1	Contrast MediaIBA 01/2018
1	sigma Receptors (sigma Receptor)IBA 01/2018
1	Ferrosoferric Oxide (Magnetite)FDA Link 01/2018
1	AlginatesIBA 07/2015
1	Capsules (Microcapsules)IBA 07/2015
1	Methotrexate (Mexate)FDA LinkGeneric 07/2015
1	oligochitosanIBA 07/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 06/2012

Therapy/Procedure

8	Therapeutics 12/2023 - 04/2010
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
1	Lasers (Laser) 12/2021
1	Aftercare (After-Treatment) 12/2021